2024
DOI: 10.1016/j.bcab.2024.103250
|View full text |Cite
|
Sign up to set email alerts
|

Using advanced biotechnological techniques to improve cannabis cultivars

Salma Shujat,
Gregory Ian Robinson,
Farzaneh Norouzkhani
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 197 publications
0
1
0
Order By: Relevance
“…Additionally, cannabis micropropagation allows for rapid multiplication while maintaining genetic integrity. Integrating gene editing methods to modify RNA and regulate gene expression within cannabis offers further tools to precisely control or modify biosynthetic pathways, thereby achieving desired cannabis characteristics [170] . However, the biosynthetic origin and genetic regulation of many potentially therapeutically relevant compounds is still unknown, limiting the possibilities of controlling biochemical pathways, as metabolic engineering in yeast and cell-free platforms are not yet compatible with commercial-scale production, while molecular pharming through the development of cell cultures is complicated by the complexity of cannabinoids at low molar concentrations [188] …”
Section: The Plant’s Chemical Constitutionmentioning
confidence: 99%
“…Additionally, cannabis micropropagation allows for rapid multiplication while maintaining genetic integrity. Integrating gene editing methods to modify RNA and regulate gene expression within cannabis offers further tools to precisely control or modify biosynthetic pathways, thereby achieving desired cannabis characteristics [170] . However, the biosynthetic origin and genetic regulation of many potentially therapeutically relevant compounds is still unknown, limiting the possibilities of controlling biochemical pathways, as metabolic engineering in yeast and cell-free platforms are not yet compatible with commercial-scale production, while molecular pharming through the development of cell cultures is complicated by the complexity of cannabinoids at low molar concentrations [188] …”
Section: The Plant’s Chemical Constitutionmentioning
confidence: 99%